Immediate-release oxycodone has a half-life of roughly three to four hours, meaning the drug’s blood concentration drops by half in that window and most of its pain-relieving effect fades within four to six hours after a single dose. Extended-release formulations are designed to stretch that timeline to about twelve hours. But “wearing off” means different things depending on whether you care about pain relief, side effects like drowsiness, drug-test detection, or the onset of withdrawal, and each of those timelines is different.
Immediate-Release Versus Extended-Release Timelines
The most important variable controlling how long oxycodone lasts is the formulation. Immediate-release tablets and liquid solutions release their full dose into the bloodstream quickly, reaching peak levels within about an hour or two. From that peak, the drug’s concentration falls with a half-life of three to four hours. After roughly four to five half-lives, the drug is considered essentially cleared from the blood, which puts total elimination somewhere around 15 to 20 hours for a single immediate-release dose. Pain relief, though, doesn’t last that long because the concentration drops below the therapeutic threshold well before the drug is fully gone. Most people notice their pain returning within four to six hours after taking an immediate-release tablet.
Extended-release (also called controlled-release) oxycodone is engineered to meter the drug out slowly. Its effective half-life stretches to roughly 12 hours, which is why it’s typically dosed twice a day rather than every four to six hours.1PubMed. Oxycodone: a pharmacological and clinical review Full clearance from the body after a single extended-release dose can take more than two days. If you’ve been taking the extended-release version on a regular schedule, residual drug from earlier doses overlaps with each new one, so the effective “wearing off” period after your last pill stretches further still.
What Happens in the Liver and Why It Matters
Your liver does most of the work breaking oxycodone down into metabolites that can be excreted. Two enzyme families handle the heavy lifting. One, called CYP3A4 (along with the closely related CYP3A5), converts oxycodone into noroxycodone, which is the major metabolic pathway. The other, CYP2D6, converts it into oxymorphone, a metabolite that is itself a potent painkiller.2Drug Metabolism and Disposition. Quantitative Contribution of CYP2D6 and CYP3A to Oxycodone Metabolism in Human Liver and Intestinal Microsomes The relative speed of these two pathways shapes how quickly the drug clears your system and, to some degree, how strong its effects feel.
This matters because the activity of both enzyme families varies from person to person. Some people are genetically “poor metabolizers” for CYP2D6, meaning their bodies produce less oxymorphone. One study of post-surgical patients found that poor metabolizers of CYP2D6 made dramatically less oxymorphone, confirming the enzyme’s role, yet their overall pain relief from intravenous oxycodone was not measurably different from that of normal metabolizers.3PubMed. Impact of the CYP2D6 genotype on post-operative intravenous oxycodone analgesia That said, genetic variation in CYP2D6 and CYP3A is increasingly linked to differences in how patients respond to oxycodone overall, and ongoing pharmacogenomics research is working to clarify when those differences are clinically meaningful.4PubMed Central. Pharmacogenomics of oxycodone: a narrative literature review
Drugs That Speed Up or Slow Down Clearance
Because oxycodone depends on CYP3A4 and CYP2D6 for its breakdown, anything that blocks or boosts those enzymes changes how long the drug sticks around. When researchers gave healthy volunteers ketoconazole (a potent CYP3A4 blocker) before oxycodone, oxycodone’s blood levels roughly doubled or tripled, and side effects like nausea, drowsiness, and itching intensified.5PubMed. Effect of the inhibition of CYP3A4 or CYP2D6 on the pharmacokinetics and pharmacodynamics of oxycodone Blocking CYP3A4 also shunted more oxycodone through the CYP2D6 pathway, tripling oxymorphone levels.6PubMed Central. The effects of CYP2D6 and CYP3A activities on the pharmacokinetics of immediate release oxycodone In practical terms, common CYP3A4 inhibitors include certain antifungal medications, some antibiotics, and grapefruit juice in large amounts. If you’re taking any of these alongside oxycodone, the drug effectively wears off more slowly and hits harder.
The opposite problem occurs with enzyme inducers. Drugs like rifampicin, carbamazepine, and the herbal supplement St. John’s wort rev up CYP3A4 activity, causing oxycodone to be broken down faster than expected. The result can be subtherapeutic oxycodone levels, meaning the drug wears off sooner and provides less pain relief. Simultaneously blocking both CYP3A4 and CYP2D6 is especially risky, because it leaves oxycodone with no efficient route out of the body and can raise concentrations to dangerous levels.7PubMed. Cytochrome P450-mediated changes in oxycodone pharmacokinetics/pharmacodynamics and their clinical implications
How Age Affects the Timeline
Older adults clear oxycodone more slowly. A population pharmacokinetic study found that oxycodone’s elimination half-life climbs in a roughly linear way with advancing age. For a reference 25-year-old, the context-sensitive half-time at steady state was about 3.8 hours; by age 85, it had risen to about 4.6 hours. Simulations in that study showed roughly a 20 percent increase in oxycodone blood concentration in elderly patients compared with younger adults receiving identical doses.8BJA: British Journal of Anaesthesia. Oxycodone clearance is markedly reduced with advancing age: a population pharmacokinetic study
The reasons are straightforward. Kidney filtration rate (GFR) declines with age, and research in older post-surgical patients found a clear correlation between GFR and oxycodone clearance.9PubMed. Elimination of intravenous oxycodone in the elderly: a pharmacokinetic study in postoperative orthopaedic patients of different age groups Lean body mass also drops, which affects distribution volume. Both factors mean the drug lingers longer per dose. For people with significant kidney impairment regardless of age, oxycodone should be used cautiously and with close monitoring, since metabolites that are normally excreted by the kidneys can accumulate.10PubMed Central. Opioids in renal failure and dialysis patients
How Long Oxycodone Shows Up on a Drug Test
“Wearing off” in the context of drug testing is a completely separate question from pain relief. Oxycodone and its metabolites remain detectable in urine long after the subjective effects fade. In a controlled study, peak urine concentrations of oxycodone and its metabolites appeared within about eight hours of dosing and declined below a common laboratory threshold of 300 ng/mL within 24 to 48 hours. Using standard immunoassay tests with a 300 ng/mL cutoff, oxycodone was detectable for roughly 6 to 24 hours after a dose.11PubMed. Forensic drug testing for opiates. VI. Urine testing for hydromorphone, hydrocodone, oxymorphone, and oxycodone with commercial opiate immunoassays and gas chromatography-mass spectrometry
Those windows apply to a single dose in someone who doesn’t take opioids regularly. Chronic use extends detection because the drug and its metabolites build up in tissues and are released gradually. In hair testing, opioids can show up for 90 days. Blood and saliva windows are shorter, typically matching or slightly exceeding the drug’s pharmacological duration. If you’re concerned about a specific testing scenario, the type of test, the cutoff concentration used, and how long you’ve been taking the medication all matter more than any single number.
Drowsiness, Driving, and How Long Impairment Lasts
Many people want to know when it’s safe to drive after taking oxycodone. The research here is more nuanced than you might expect. In a placebo-controlled study, 10 mg of oxycodone produced measurable increases in self-reported sedation and feelings of impairment in healthy volunteers, yet objective driving performance on a simulator wasn’t statistically different from placebo at that dose.12PubMed Central. Acute administration of oxycodone, alcohol and their combination on simulated driving – preliminary outcomes in healthy adults A separate driving study using an oxycodone-paracetamol combination found a similar pattern: volunteers said they needed significantly more effort to perform the driving test and reported increased sedation, even though their measurable performance didn’t decline significantly.13The Clinical Journal of Pain. Effects of an Opioid (Oxycodone/Paracetamol) and an NSAID (Bromfenac) on Driving Ability, Memory Functioning, Psychomotor Performance, Pupil Size, and Mood
That doesn’t mean oxycodone is safe to drive on. Both studies used single acute doses in healthy, opioid-naïve volunteers under controlled conditions. Real-world driving involves fatigue, distraction, and split-second reactions that lab simulators can’t fully capture. A broader review of the evidence concluded that the contexts most clearly associated with driving impairment are illicit opioid use, the initiation phase of therapy (when your body hasn’t adjusted), and taking opioids alongside other sedating medications like benzodiazepines or alcohol.14PubMed Central. Opioid Use and Driving Performance If you’re just starting oxycodone or changing doses, assume you’re impaired for at least several hours after each dose, and possibly longer.
Does Food Change How Quickly It Wears Off?
People often wonder whether taking oxycodone with a meal slows it down or changes its effectiveness. The answer depends on the formulation. For the immediate-release liquid solution, eating a high-fat meal increased total drug absorption by about 20 percent while lowering the peak concentration to roughly 82 percent of what it would be on an empty stomach.15PubMed. Differential effects of food on the bioavailability of controlled-release oxycodone tablets and immediate-release oxycodone solution In plain terms, you absorb slightly more of the drug overall but the peak is blunted and spread out, so the onset of relief might feel slightly delayed.
For controlled-release tablets, the story is simpler. Studies consistently show that food has little meaningful effect on how much drug you absorb or how high levels peak.16PubMed. Effect of food on the pharmacokinetics of oxycodone and naltrexone from ALO-02, an extended release formulation of oxycodone with sequestered naltrexone An additional study of a tamper-deterrent immediate-release tablet found that food caused only a small reduction in peak concentration (about 14 percent) and a modest rise in overall absorption (about 21 percent), both considered clinically unimportant.17Clinical Therapeutics. Dose Proportionality and the Effects of Food on Bioavailability of an Immediate-Release Oxycodone Hydrochloride Tablet Designed to Discourage Tampering In practice, you can take oxycodone with or without food, though eating with it may soften stomach upset.
Steady State and Repeated Dosing
If you’re taking oxycodone on a regular schedule for chronic pain, the concept of “wearing off” shifts. When immediate-release oxycodone is taken at 10 mg every four hours, studies show no significant accumulation at steady state, meaning the amount entering and leaving the body each cycle reaches a stable equilibrium.18PubMed. Single-dose and steady-state pharmacokinetics and pharmacodynamics of oxycodone in patients with cancer That’s partly why the every-four-hours dosing schedule works: the drug has time to largely clear before the next dose replenishes it.
Tolerance also enters the picture with repeated dosing. In a controlled study where healthy volunteers took oxycodone daily for five days, the painkilling effect held steady, but tolerance developed to some of the subjective “good feeling” effects of the drug. Interestingly, when the same drug was given intermittently instead of daily, the pain-relieving effect actually appeared to increase by the fifth day rather than diminish.19PubMed Central. Effects of repeated oxycodone administration on its analgesic and subjective effects in normal, healthy volunteers These findings are from short-term controlled conditions and don’t necessarily map onto what happens over months of chronic use, but they suggest that analgesic tolerance to therapeutic doses isn’t as rapid as people sometimes fear.
When Withdrawal Begins
For anyone who has been taking oxycodone regularly, “wearing off” eventually means withdrawal. The onset of withdrawal symptoms tracks closely with the drug’s pharmacological timeline. For short-acting oxycodone, early withdrawal signs typically start within 6 to 10 hours after the last dose.20PubMed Central. Alleviating Symptoms of Withdrawal from an Opioid Early symptoms often include anxiety, muscle aches, sweating, and yawning. These tend to peak within one to three days and gradually improve over a week, though some symptoms like insomnia and low mood can persist for weeks.
With extended-release formulations, withdrawal onset is delayed somewhat, reflecting the longer effective half-life. How severe withdrawal is depends on how long you’ve been taking the drug, the dose, and individual physiology. Tapering gradually under medical guidance is the standard approach to minimizing withdrawal rather than stopping abruptly.
Naloxone and the Risk of Re-Narcotization
In overdose situations, naloxone (Narcan) can reverse the life-threatening effects of oxycodone within minutes. But there’s a critical timing mismatch: naloxone’s duration of action is shorter than oxycodone’s. After a single dose of naloxone, the reversal may wear off while oxycodone is still active in the body, causing the person to slip back into respiratory depression. This risk is especially pronounced when someone has taken a large dose of oxycodone or has used an extended-release formulation, because the opioid continues to be released into the bloodstream long after the naloxone has been cleared.21PubMed Central. Naloxone dosage for opioid reversal: current evidence and clinical implications Anyone who receives naloxone for an oxycodone overdose needs continued monitoring, not just a single dose and a sigh of relief. Repeated naloxone administration or a continuous infusion may be necessary to keep pace with the opioid’s longer presence in the body.